© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat
aDepartment of Cardiovascular Surgery and INSERM U 572, Hôpital Européen Georges Pompidou, 20, rue Leblanc, 75015 Paris, Cedex, France
bINSERM U 523, Institut de Myologie, Hôpital Pitié-Salpêtrière, Paris, France
cDepartment of Cardiology, Hôpital Européen Georges Pompidou and Faculté de Médecine Necker-Paris V, Paris, France
* Corresponding author. Tel.: +33-1-5609-3622; fax: +33-1-5609-2219. philippe.menasche{at}hop.egp.ap-hop-paris.fr
Background: Several studies have demonstrated the short-term benefits of autologous skeletal muscle cell transplantation on postinfarction left ventricular function. The present experiments were designed to assess the long-term effects of the procedure. Methods and results: Thirteen Wistar rats that had undergone skeletal muscle cell transplantation (n = 6) or injection of control culture medium (n = 7) in isoforms areas after myocardial infarction created by coronary artery ligation and survived for 1 year were functionally assessed by combining echocardiography and pressure–volume loops. At 1 year after transplantation, both contractile and relaxation indices were significantly improved in the skeletal muscle cell-grafted group compared with controls. One-year echocardiographic measurements of ejection fraction were similar to those recorded 2 months after the procedure. The stability of the functional outcome contrasted with a decrease in the number of histologically detectable skeletal myotubes over time. However, the proportion of the slow and composite (fast and slow) myosin isoforms expressed by skeletal muscle fibers still present after 1 year was greater than that found in animals sacrificed after 2 months. Conclusion: The functional benefits of autologous skeletal muscle cell transplantation are sustained over time and are associated with either selection, preservation or an increased expression of slow myosin heavy chain isoforms. The discrepancy between maintenance of this improvement and the decay in the engrafted myotubes suggests protective mechanisms operative from the early post-transplantation stage and possibly involving modulation of extracellular matrix remodelling or paracrinally induced maturation of putative cardiac resident stem cells.
KEYWORDS Contractile apparatus; Heart failure; Histo(patho)logy; Infarction; Transplantation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Q. Ly and S. Nattel Stem Cells Are Not Proarrhythmic: Letting the Genie out of the Bottle Circulation, April 7, 2009; 119(13): 1824 - 1831. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Agbulut, A. Huet, N. Niederlander, M. Puceat, P. Menasche, and C. Coirault Green Fluorescent Protein Impairs Actin-Myosin Interactions by Binding to the Actin-binding Site of Myosin J. Biol. Chem., April 6, 2007; 282(14): 10465 - 10471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Agbulut, M. Mazo, C. Bressolle, M. Gutierrez, K. Azarnoush, L. Sabbah, N. Niederlander, G. Abizanda, E. J. Andreu, B. Pelacho, et al. Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovasc Res, October 1, 2006; 72(1): 175 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Messas, A. Bel, M. C. Morichetti, C. Carrion, M. D. Handschumacher, S. Peyrard, J. T. Vilquin, M. Desnos, P. Bruneval, A. Carpentier, et al. Autologous Myoblast Transplantation for Chronic Ischemic Mitral Regurgitation J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2086 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Kolettis Arrhythmogenesis after cell transplantation post-myocardial infarction. Four burning questions-And some answers Cardiovasc Res, February 1, 2006; 69(2): 299 - 301. [Full Text] [PDF]
|
|
|
|
|
|
S. Fernandes, J.-C. Amirault, G. Lande, J.-M. Nguyen, V. Forest, O. Bignolais, G. Lamirault, D. Heudes, J.-L. Orsonneau, M.-F. Heymann, et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias Cardiovasc Res, February 1, 2006; 69(2): 348 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ye, H. K. Haider, and E. K. W. Sim Adult Stem Cells for Cardiac Repair: A Choice Between Skeletal Myoblasts and Bone Marrow Stem Cells Experimental Biology and Medicine, January 1, 2006; 231(1): 8 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ye, H. Kh. Haider, S. Jiang, L. H. Ling, R. Ge, P. K. Law, and E. K.W. Sim Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model Eur J Heart Fail, October 1, 2005; 7(6): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dow, B. Z. Simkhovich, L. Kedes, and R. A. Kloner Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy Cardiovasc Res, August 1, 2005; 67(2): 301 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Abraham, C. A. Henrikson, L. Tung, M. G. Chang, M. Aon, T. Xue, R. A. Li, B. O' Rourke, and E. Marban Antiarrhythmic Engineering of Skeletal Myoblasts for Cardiac Transplantation Circ. Res., July 22, 2005; 97(2): 159 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Wollert and H. Drexler Clinical Applications of Stem Cells for the Heart Circ. Res., February 4, 2005; 96(2): 151 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Agbulut, S. Vandervelde, N. Al Attar, J. Larghero, S. Ghostine, B. Leobon, E. Robidel, P. Borsani, M. Le Lorc'h, A. Bissery, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium J. Am. Coll. Cardiol., July 21, 2004; 44(2): 458 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barandon Editorial comment: Cellular cardiomyoplasty: 'inject is easy, demonstrate is complicated' Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 350 - 351. [Full Text] [PDF]
|
|